Cardiac Guidance vs Acumen Hypotension Prediction Index (HPI) Feature Software
AI Verdict
Choose Cardiac Guidance if…
Choose Cardiac Guidance if your primary need is to empower healthcare professionals, including those without extensive ultrasound expertise, to acquire diagnostic-quality cardiac ultrasound images at the point of care. This tool is ideal for democratizing access to critical cardiac assessments, enabling early disease detection and rapid diagnostic support in settings like emergency departments or critical care where immediate cardiac imaging is crucial.
View Cardiac Guidance →Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…
Choose Acumen Hypotension Prediction Index (HPI) if your focus is on proactively preventing hypotensive events in critically ill or surgical patients. This software is best suited for environments requiring continuous hemodynamic monitoring, such as operating rooms or ICUs, where its machine learning capabilities can predict hypotension up to 15 minutes in advance, enabling timely interventions to improve patient outcomes.
View Acumen Hypotension Prediction Index (HPI) Feature Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiac Guidance | Acumen Hypotension Prediction Index (HPI) Feature Software |
|---|---|---|
| Deployment | Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care. | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiac GuidanceCardiac Guidance (Tool A) is specifically designed to enable non-expert ultrasound users to acquire diagnostic-quality images through real-time AI guidance, turn-by-turn instructions, and automated quality assessment. Clinical studies have shown that nurses with minimal training can successfully use the software to obtain high-quality echocardiograms. This focus on democratizing a complex skill for a broader range of healthcare professionals gives it a significant edge in usability over Acumen HPI, which, while providing clear data, still requires interpretation of complex hemodynamic parameters.
Clinical Value
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI (Tool B) demonstrates a direct and quantifiable impact on patient outcomes by predicting hypotensive events up to 15 minutes before they occur, enabling proactive intervention. Multiple clinical studies, including a multicenter registry, have shown a significant reduction in the incidence, duration, and severity of intraoperative hypotension with its use. While Cardiac Guidance (Tool A) offers substantial value by expanding access to diagnostic imaging, Acumen HPI's proven ability to prevent critical adverse events directly translates to improved patient safety and outcomes in acute care settings.
Pricing & Value
Cardiac GuidanceWhile both tools require contacting the vendor for pricing, Cardiac Guidance (Tool A) has a distinct advantage due to its New Technology Add-on Payment (NTAP) status from CMS. This designation provides reimbursement for hospitals, covering a significant portion of costs for Medicare patients across various cardiac-related diagnostic groups. This directly addresses financial barriers to adoption, enhancing its overall value proposition for healthcare institutions.
Enterprise Readiness
TieBoth tools exhibit strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Cardiac Guidance (Tool A) benefits from its acquisition by GE HealthCare, promising integration into a broader digital ecosystem and compatibility with various ultrasound systems. Acumen HPI (Tool B) is deeply integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform, which includes EMR integration and remote access capabilities. Both are well-equipped for deployment within large healthcare systems.
Innovation
TieBoth tools represent significant innovation in their respective fields. Cardiac Guidance (Tool A) is a first-of-its-kind AI-guided imaging acquisition software, democratizing a highly skilled diagnostic procedure by enabling non-experts to perform cardiac ultrasounds. Acumen HPI (Tool B) is also a first-of-its-kind predictive monitoring tool, leveraging machine learning to anticipate critical physiological events like hypotension, shifting care from reactive to proactive. Each addresses a unique and substantial challenge in healthcare through novel AI applications.
Support & Docs
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI (Tool B) explicitly outlines a comprehensive 'HemoSphere 360 software and service program' that includes 24/7 technical support, extended warranty coverage, expedited shipping and service, and continuous software updates. Additionally, Edwards Lifesciences provides extensive clinical education resources and a protocol library. While Cardiac Guidance (Tool A) will likely benefit from GE HealthCare's support infrastructure post-acquisition, Tool B offers more concrete and detailed support offerings in its public information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiac Guidance | Acumen Hypotension Prediction Index (HPI) Feature Software |
|---|---|---|
| Tool Name | Cardiac Guidance | Acumen Hypotension Prediction Index (HPI) Feature Software |
| Company | Caption Health | Edwards Lifesciences |
| Primary Function | AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care. | Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs. |
| Core Technology/Method | Real-time AI guidance for cardiac ultrasound image acquisition, automated quality assessment, auto-capture of diagnostic-quality images and video clips. | Machine learning algorithms for predictive analysis of blood pressure waveforms, detects and helps clinicians treat hemodynamic instability. |
| Key Output/Metric | Automated quality assessment with a 'Quality Meter', automated left ventricular ejection fraction (EF) calculation, support for 10 standard echocardiographic views. | Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen, Relationship View screen providing insights into preload, afterload, and contractility. |
| Target Clinical Application | Early disease detection and accessible cardiac care through diagnostic-quality cardiac assessments. | Proactive hemodynamic management and improving patient outcomes by predicting hypotension up to 15 minutes before an event. |
| Intended User Expertise | Designed for use by non-expert ultrasound users. | Not specified |
| Compatibility/Integration | Compatible with general purpose diagnostic ultrasound systems (e.g., GE HealthCare Venue Family, Vscan Air SL, Terason uSmart 3200t Plus). | Integrated into Edwards Lifesciences HemoSphere advanced monitoring platform. Compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. |
Videos
Demos, reviews, and walkthroughs featuring Cardiac Guidance and Acumen Hypotension Prediction Index (HPI) Feature Software.